126 related articles for article (PubMed ID: 34481758)
1. COVID-19 patient with recurrent anosmia and its impact on management.
Rizki NA; Lukito PP; Helsa K; Rustandi D
Eur Ann Otorhinolaryngol Head Neck Dis; 2022 Mar; 139(2):115-116. PubMed ID: 34481758
[No Abstract] [Full Text] [Related]
2. Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19.
Lechien JR; Chiesa-Estomba CM; Hans S; Saussez S
J Intern Med; 2021 Aug; 290(2):464-465. PubMed ID: 33527593
[No Abstract] [Full Text] [Related]
3. Olfactory disorder in patients infected with SARS-CoV-2.
Yen YF; Lai HH; Chan SY; Su VY; Chiu TF; Huang CY; Hung CC; Kuo TL; Lee YL; Chu D
J Microbiol Immunol Infect; 2021 Oct; 54(5):992-996. PubMed ID: 32859529
[TBL] [Abstract][Full Text] [Related]
4. [Loss of smell, a preliminary indicator of COVID-19].
Waizel-Haiat S; Waizel-Bucay J
Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-related anosmia.
Kanaganayagam E; Lloyd G; Travers L; Morris J; Chang A
Aust J Gen Pract; 2022 Apr; 51():. PubMed ID: 35393605
[TBL] [Abstract][Full Text] [Related]
6. Anosmia during acute COVID-19 and psychiatric outcomes 4 months later: Results from the prospective COMEBAC cohort.
Faulet T; Gasnier M; Lecoq AL; Morin L; Choucha W; Montani D; Monnet X; Becquemont L; Corruble E; Colle R;
Gen Hosp Psychiatry; 2023; 84():260-261. PubMed ID: 37328360
[No Abstract] [Full Text] [Related]
7. Anosmia and loss of smell in the era of covid-19.
Walker A; Pottinger G; Scott A; Hopkins C
BMJ; 2020 Jul; 370():m2808. PubMed ID: 32694187
[No Abstract] [Full Text] [Related]
8. What Is Anosmia?
Huynh PP; Ishii LE; Ishii M
JAMA; 2020 Jul; 324(2):206. PubMed ID: 32556300
[No Abstract] [Full Text] [Related]
9. Strategies for Evaluating Anosmia Therapeutics in the COVID-19 Era-Coming to Our Senses.
Roland LT; Levy JM
JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):837-839. PubMed ID: 35797021
[No Abstract] [Full Text] [Related]
10. [From pathophysiology to therapeutic management of loss of smell in Covid-19].
Nguyen DT; Masson V; Jankowski R; Toussaint B; Gallet P; Rumeau C; Chenuel B
Rev Prat; 2021 Jan; 71(1):13-19. PubMed ID: 34160932
[No Abstract] [Full Text] [Related]
11. Beware of traumatic anosmia in COVID-19 pandemic.
Nagamine T
CJEM; 2021 Jul; 23(4):567-568. PubMed ID: 33881763
[No Abstract] [Full Text] [Related]
12. COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.
Rethinavel HS; Ravichandran S; Radhakrishnan RK; Kandasamy M
J Chem Neuroanat; 2021 Sep; 115():101965. PubMed ID: 33989761
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of cases of anosmia and COVID-19.
Sookaromdee P; Wiwanitkit V
Braz J Otorhinolaryngol; 2021; 87(5):638. PubMed ID: 33992555
[No Abstract] [Full Text] [Related]
14. Assessing Efficacy Using Variations of Olfactory Training for COVID-19-Related Smell Loss-Would a Rose by Any Other Scent Smell as Strong?
Yan CH
JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):149-150. PubMed ID: 36580290
[No Abstract] [Full Text] [Related]
15. [COVID-19-associated anosmia].
Meller AE; Fokeev VA; Shakhova MA; Shakhov AV
Vestn Otorinolaringol; 2023; 88(3):63-68. PubMed ID: 37450393
[TBL] [Abstract][Full Text] [Related]
16. In Response to Anosmia and Ageusia: Common Findings in COVID-19 Patients.
Vaira LA; Salzano G; Deiana G; De Riu G
Laryngoscope; 2020 Nov; 130(11):E695. PubMed ID: 32673407
[No Abstract] [Full Text] [Related]
17. The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients.
Vaira LA; Lechien JR; Salzano G; Maglitto F; Saussez S; De Riu G
Am J Otolaryngol; 2022; 43(3):103301. PubMed ID: 34895763
[No Abstract] [Full Text] [Related]
18. New study on prevalence of anosmia in COVID-19 implicates the D614G virus mutation as a major contributing factor to chemosensory dysfunction.
von Bartheld CS; Mathew D; Butowt R
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3593-3594. PubMed ID: 33788036
[No Abstract] [Full Text] [Related]
19. Chemosensory loss in COVID-19.
Xu W; Sunavala-Dossabhoy G; Spielman AI
Oral Dis; 2022 Nov; 28 Suppl 2():2337-2346. PubMed ID: 35790059
[TBL] [Abstract][Full Text] [Related]
20. Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.
Ojha P; Dixit A
Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):462-473. PubMed ID: 35090056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
